Skip to main content
Premium Trial:

Request an Annual Quote

Greg Lucier, Mark Stevenson, David Hoffmeister, Tony White, Michael Egholm, Jason Affourtit, Brian Desany, David Bentley, Sean Humphray, Tony Cox, Scott Kahn, Keira Cheetham, Francisco De La Vega, Clarence Lee, Gina Costa, Kevin McKernan, Fiona Hyland, He

Greg Lucier, chairman, president, and CEO of Invitrogen, will become CEO of Applied Biosystems following Invitrogen’s planned acquisition of the company.  
Mark Stevenson, president and chief operating officer of ABI, will retain that role in the new company.
David Hoffmeister, senior vice president of finance and chief financial officer of Invitrogen, will remain CFO of the new ABI.
Tony White, chairman, president, and CEO of ABI’s parent Applera, will become an unpaid consultant to the new company for a period of five years.

Representatives from 454 Life Sciences, Illumina, and Applied Biosystems have joined a variety of committees and groups of the 1000 Genomes Project after their companies said they would participate in it.
For 454 Life Sciences, Michael Egholm, vice president of R&D, has joined the steering committee, the samples and ELSI group, and the production group; Jason Affourtit, group leader for advanced technologies integration, and Brian Desany, a senior bioinformatics scientist, have become members of the production group, the analysis group, and the data flow group.
For Illumina, Chief Scientist David Bentley has become a member of the steering committee; Sean Humphray, manager of scientific research, has joined the samples and ELSI group, the production group, the analysis group, and the data flow group; senior scientist Tony Cox and vice president and chief information officer Scott Kahn have joined the analysis group and the data flow group; and scientist Keira Cheetham has become a member of the analysis group.
For ABI, Francisco De La Vega, vice president for SOLiD system applications and bioinformatics, has joined the steering committee, the production group, the analysis group, and the data flow group; Clarence Lee, an R&D senior scientist, has joined the samples and ELSI group; Gina Costa, director of R&D projects, and Kevin McKernan, senior director for scientific operations, have become members of the production group; Fiona Hyland and Heather Peckham, both R&D staff scientists for bioinformatics, have joined the analysis group; and Tim Hunkapiller, a consultant to ABI, has become a member of the data flow group.

Gunther Stent died at age 84. He was chairman of the department of molecular biology at the University of California, Berkeley, from 1980 to 1986. Earlier, he was an associate of Max Delbrück at the California Institute of Technology, studying bacteriophages. As part of his research, Stent helped to validate the double helix structure of DNA. Born in Germany, he emigrated to the US during the Nazi regime, where he obtained a bachelor’s degree and a PhD in chemistry from the University of Illinois.

Ratan Tata and Michael Boustridge have joined the board of trustees of the X Prize Foundation. Tata is the chairman of Tata Sons, the holding company of the Tata Group of India. He holds a BS in architecture from Cornell University. Boustridge is the president of BT Americas, one of four regions of BT Global Services.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.